Analysts expect Walgreens Boots Alliance Inc (NASDAQ:WBA) to report earnings of $1.53 per share for the current fiscal quarter, Zacks Investment Research reports. Nine analysts have provided estimates for Walgreens Boots Alliance’s earnings, with estimates ranging from $1.44 to $1.59. Walgreens Boots Alliance reported earnings of $1.36 per share in the same quarter last year, which indicates a positive year over year growth rate of 12.5%. The firm is scheduled to report its next earnings report on Wednesday, April 4th.
According to Zacks, analysts expect that Walgreens Boots Alliance will report full year earnings of $5.72 per share for the current year, with EPS estimates ranging from $5.45 to $5.95. For the next financial year, analysts anticipate that the company will post earnings of $6.31 per share, with EPS estimates ranging from $5.93 to $6.74. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that follow Walgreens Boots Alliance.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The business had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The firm’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter last year, the business posted $1.10 EPS.
In other Walgreens Boots Alliance news, insider Stefano Pessina purchased 98,858 shares of the stock in a transaction dated Monday, January 15th. The shares were bought at an average price of $76.07 per share, with a total value of $7,520,128.06. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 14.80% of the company’s stock.
Hedge funds and other institutional investors have recently bought and sold shares of the company. Hudock Capital Group LLC boosted its position in Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 6 shares during the period. Northern Capital Management LLC raised its position in shares of Walgreens Boots Alliance by 0.4% during the second quarter. Northern Capital Management LLC now owns 6,635 shares of the pharmacy operator’s stock valued at $520,000 after buying an additional 25 shares during the last quarter. MAI Capital Management raised its position in shares of Walgreens Boots Alliance by 0.6% during the second quarter. MAI Capital Management now owns 5,272 shares of the pharmacy operator’s stock valued at $413,000 after buying an additional 34 shares during the last quarter. Truepoint Inc. raised its position in shares of Walgreens Boots Alliance by 0.5% during the second quarter. Truepoint Inc. now owns 8,614 shares of the pharmacy operator’s stock valued at $698,000 after buying an additional 39 shares during the last quarter. Finally, Girard Partners LTD. raised its position in shares of Walgreens Boots Alliance by 1.9% during the second quarter. Girard Partners LTD. now owns 3,053 shares of the pharmacy operator’s stock valued at $239,000 after buying an additional 56 shares during the last quarter. 61.24% of the stock is currently owned by institutional investors.
Walgreens Boots Alliance (NASDAQ:WBA) traded down $0.24 during trading hours on Monday, hitting $71.29. 529,482 shares of the stock traded hands, compared to its average volume of 5,865,479. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. The company has a market capitalization of $71,120.13, a P/E ratio of 19.76, a PEG ratio of 1.21 and a beta of 1.18. Walgreens Boots Alliance has a one year low of $63.82 and a one year high of $88.00.
Walgreens Boots Alliance announced that its board has initiated a stock repurchase plan on Wednesday, October 25th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to buy shares of its stock through open market purchases. Shares repurchase plans are typically an indication that the company’s leadership believes its stock is undervalued.
The firm also recently declared a quarterly dividend, which will be paid on Monday, March 12th. Stockholders of record on Thursday, February 15th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 2.24%. The ex-dividend date of this dividend is Wednesday, February 14th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 44.20%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.